| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |